Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
Premaitha is attending the Taiwan Healthcare+ Expo, 29 November-2 December 2018 and Robert Henke (Area Director, Asia Pacific) is presenting on behalf Yourgene Health, under the ‘BioInnovation Stadium: From Entrepreneurship to Ecosystem’ umbrella of presenters, along with the likes of Johnson & Johnson. It’s got 1400 booths and 400 exhibitors over the 3 days and we now know that the new name will be in full use by this time, so an excellent time to pump the new brand and the new strategy, once that is finalised by Lyn and the rest of the Board.
Lyn is definitely on an IR offensive, which bodes well. One would expect the level of transparency around future forecasts and KPI’s to be evident at the AGM.
That’s much better isn’t it. Last years interims weren’t published until 29th December, so 3rd of December or earlier is a clear statement of how Lyn will be improving communication efficiencies.
It’s great that we are now getting this level of transparency around potential revenue, and I would imagine this is now the new norm with the litigation out of the way. Great news and no doubt there will be more over the coming months.
I haven’t had a response from Premaitha after my morning email to them but as their reporting date within the financial calendar on the website says 30th September, which is Sunday so then it’s quite feasible they will publish Monday pre market open.
I think everyone needs to chill out frankly.
I’ve emailed the company and specifically asked when the results will be published on the basis that to comply with AIM regulations, I believe it has to be today, unless there is a caveat that I am unaware of that allows them to do it before the LSE opens on Monday with the last actual reporting day being ‘officially’ on Sunday 30th.
I’ll let you know what response I get.
I’ve been questioning for a while why a CEO of Lyn’s calibre and specific acquisitive background would join a business such as Premaitha if it was simply to get to a TO position. Clearly, the way we are now aligned to Illumina and TF does indeed set us up nicely for a potential TO or multiple TO’s, if Notaflippers suggestion comes to fruition (will be nice if it does). However, I actually believe that regardless of how soon we do or do not arrive in that position, Premaitha will potentially make a number of acquisitions, although I haven’t got to the point of identifying where the biggest value add acquisition would be at this stage. Just my personal view but I’d love to hear people’s thoughts.
Spot on Dave, that encapsulates where my thought process is at the moment. I find this BB really interesting a lot of the time with the consistent quality contributors (we all know who they are) adding a lot of value for me and validating my thought process and investment plan, or getting me to consider stuff I had not maybe considered. My goodness though, during periods of low news output like now, it’s like a ground hogg day scenario going round and round in circles and to be honest, it can be somewhat exhausting and it’s often easier to turn it off and come back a few days later or when the inevitable RNS pops up.
They’re advertising for a Manufacturing & Logistics Manager role today, which reports to their Head of Operations and will be based in Manchester. It’s not an Executive level role and I don’t know if it’s to replace a leaver or is a new role but either way, it’s generally not the practise of organisations to recruit for personnel to be based in a country they are about to exit. I appreciate that even if they were to exit the UK, they have other non UK operations that could continue to be run from the Manchester Head Office but if there was still uncertainty about the strategy moving forward, at the very least there would no doubt be a recruitment freeze until they have better clarity, in my experience anyway,
Nothing groundbreaking but gives some more detail on the winders that will be used and that they have now been manufactured and are ready to be transported to site basically.
https://im-mining.com/2018/07/09/olko-gets-contract-two-winders-sirius-minerals-york-polyhalite-project/
It really is excellent news and shows that Premaitha is investing in the right people to support the growth plans of the business moving forward. Lyn knows what a good business looks like with BBI Group and has a fantastic track record in the areas that we are going to benefit greatly from; new product offerings, aggressive growth plans, top tier partnerships etc etc. Exciting stuff from my point of view.
http://www.india.com/news/agencies/neuberg-diagnostics-partners-with-uks-premaitha-health-3140655/
I imagine this will be announced via RNS Monday morning as it was announced in India on Saturday. Neuberg seem to have on the ground representation in India, UAE and South Africa, so an interesting geographical footprint. More positive news obviously but we are all more keen to hear about something related to the litigation / potential settlement . Tick tock, tick tock.
Thanks Sorcerer and Helcon, good ideas and I’m secretely glad that I’m not the only one to be stumped.
I’m having a discussion with my wife about Premaitha and explaining why I’m invested in it. She asked s question I can’t answer even as a LTH, so a gold star to anyone who is able to help with the answer.... Why is the company called Premaitha and what does it mean?
It is feasible that they are waiting to collate data from the Middle East, as the start of their working week is Sunday and I’d imagine that’s quite s big market for them now. If they want to make sales figures look as good as possible, we may still get something by the end of the day.
Whoever said silence is golden, was clearly not thinking about Premaitha when they said it. At least we will have something tangible by the weekend. It may be ambiguous tangible mind :)
Illumina certainly love a patent infringement case don�t they; just seen this issued today....... https://www.genomeweb.com/molecular-diagnostics/illumina-sues-natera-nipt-patent-infringement
Clearly we are all hoping that break even is achieved sooner rather than later and if that is indeed by the end of March, then great. However, presumably we won�t actually have any visibility of that until it is officially reported, which will be retrospectively after a 3 month lag from March. Any differing views on that?
Has someone got a link to the February report please? I can’t seem to find one.